Home4503 • TYO
Astellas Pharma Inc
ÂĄ1,709.50
Sep 27, 5:45:38 PM GMT+9 · JPY · TYO · Disclaimer
StockGLeaf logoClimate leaderJP listed securityJP headquartered
Previous close
ÂĄ1,682.00
Day range
ÂĄ1,670.00 - ÂĄ1,710.50
Year range
ÂĄ1,426.00 - ÂĄ2,168.00
Market cap
3.09T JPY
Avg Volume
6.21M
P/E ratio
143.98
Dividend yield
4.09%
Primary exchange
TYO
CDP Climate Change Score
A
Financials
Income Statement
Revenue
Net income
(JPY)Jun 2024Y/Y change
Revenue
473.12B26.17%
Operating expense
328.67B25.93%
Net income
37.60B13.50%
Net profit margin
7.95-9.97%
Earnings per share
——
EBITDA
103.59B51.67%
Effective tax rate
25.53%—
Total assets
Total liabilities
(JPY)Jun 2024Y/Y change
Cash and short-term investments
302.93B-46.05%
Total assets
3.74T33.51%
Total liabilities
2.06T68.84%
Total equity
1.68T—
Shares outstanding
1.79B—
Price to book
1.80—
Return on assets
3.65%—
Return on capital
5.14%—
Net change in cash
(JPY)Jun 2024Y/Y change
Net income
37.60B13.50%
Cash from operations
12.60B3.30%
Cash from investing
-39.35B-219.91%
Cash from financing
-11.92B-107.22%
Net change in cash
-32.76B-117.74%
Free cash flow
-10.77B-238.22%
About
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Founded
Apr 1, 2005
Employees
14,754
Search
Clear search
Close search
Google apps
Main menu